Skip to main content
VulnerabilityPublished

CVE-2025-15066: Innorix WP · Path Traversal

Affects Innorix WPSource CVE Database V5

0

Not known to be exploited · CVSS 6.9 Medium.

Data as of 26 Oct 2026, 14:05 UTC

CVSS 4.0 base score
6.9Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 5% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 29 Dec 2025

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
Innorix Innorix WPAffected
  • *
Fixed in–

AI-suggested

  1. Immediately verify if the 'exam' directory exists under the Innorix WP installation path; if it is not required, remove or rename it to prevent exploitation.
  2. Implement strict input validation and sanitization on all pathname inputs within Innorix WP to ensure traversal sequences (e.g., '../') are blocked or properly handled.
  3. Restrict local access to systems running Innorix WP to trusted users only, employing strong access controls and monitoring.
  4. Monitor file system access logs for unusual or unauthorized attempts to access directories outside the intended scope, especially targeting the 'exam' directory or parent directories.
  5. If possible, isolate Innorix WP installations in segmented network zones to limit lateral movement in case of compromise.
  6. Engage with Innorix vendor support to obtain patches or official guidance once available.
  7. Conduct regular security audits and penetration testing focusing on path traversal and authorization bypass vulnerabilities.
  8. Educate system administrators and users about the risks of local privilege escalation and path traversal attacks to enhance detection and response capabilities.

Description

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'), Missing Authorization vulnerability in Innorix WP allows Path Traversal.This issue affects Innorix WP from All versions If the "exam" directory exists under the directory where the product is installed (ex: innorix/exam)

References

Community reviews

Loading reviews…